Notice2024-04199
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-IP-24-046, Nationwide Cohort To Estimate Burden of Respiratory Viruses and Immunologic Response (Blood Donor Cohort); Amended Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 29, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 41 (Thursday, February 29, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 41 (Thursday, February 29, 2024)]
[Notices]
[Page 14846]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-04199]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--RFA-IP-24-046, Nationwide Cohort To Estimate
Burden of Respiratory Viruses and Immunologic Response (Blood Donor
Cohort); Amended Notice of Closed Meeting
Notice is hereby given of a change in the closed meeting of the
Disease, Disability, and Injury Prevention and Control Special Emphasis
Panel (SEP)--RFA-IP-24-046, Nationwide Cohort to Estimate Burden of
Respiratory Viruses and Immunologic Response (Blood Donor Cohort);
April 11-12, 2024, 10 a.m.-5 p.m., EDT, videoconference, in the
original Federal Register notice. The meeting notice was published in
the Federal Register on January 16, 2024, Volume 89, Number 10, pages
2618-2619.
The notice is being amended to change the meeting dates to a one-
day meeting and should read as follows:
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--RFA-IP-24-046, Nationwide Cohort
to Estimate Burden of Respiratory Viruses and Immunologic Response
(Blood Donor Cohort).
Date: April 11, 2024.
Time: 10 a.m.-5 p.m., EDT.
The meeting is closed to the public.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National Center for HIV, Viral Hepatitis,
STD, and TB Prevention, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H24-6, Atlanta, Georgia 30329-4027.
Telephone: (404) 718-8833; Email: <a href="/cdn-cgi/l/email-protection#8acdcbe4eeeff8f9e5e4cae9eee9a4ede5fc"><span class="__cf_email__" data-cfemail="bff8fed1dbdacdccd0d1ffdcdbdc91d8d0c9">[email protected]</span></a>.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-04199 Filed 2-28-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 29, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.